These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1531214)
1. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration. Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343). Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527 [TBL] [Abstract][Full Text] [Related]
4. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462 [TBL] [Abstract][Full Text] [Related]
5. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409 [TBL] [Abstract][Full Text] [Related]
6. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170. Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634 [TBL] [Abstract][Full Text] [Related]
7. Sensitization by SR-2508 plus Ro 03-8799. Stone HB; Luu YH; Lam KN Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707 [TBL] [Abstract][Full Text] [Related]
8. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system. Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028 [TBL] [Abstract][Full Text] [Related]
9. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089 [TBL] [Abstract][Full Text] [Related]
10. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics. Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730 [TBL] [Abstract][Full Text] [Related]
11. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay. Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329 [TBL] [Abstract][Full Text] [Related]
12. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors]. Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643 [TBL] [Abstract][Full Text] [Related]
13. The development of an oral prodrug, SR-2545, of the 2-nitroimidazole radiosensitizer SR-2508. Coleman CN; Lee WW; Constine LS; Brown JM Int J Radiat Oncol Biol Phys; 1982; 8(3-4):431-4. PubMed ID: 6213588 [TBL] [Abstract][Full Text] [Related]
14. [Recent advances in hypoxic cell radiosensitizer]. Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470 [TBL] [Abstract][Full Text] [Related]
15. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization. Kagiya VT; Nishimoto S; Ito T; Wang J; Abe M; Sasai K Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitization in vitro and in vivo by 3-nitrotriazoles. Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928 [TBL] [Abstract][Full Text] [Related]
17. [Present status of radiation sensitizers--hypoxic cell radiosensitizer]. Murayama C; Mori T Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744 [TBL] [Abstract][Full Text] [Related]
18. [Radiosensitizer: hypoxic cell radiosensitizer]. Mori T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001 [TBL] [Abstract][Full Text] [Related]
19. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263). Agrawal KC; Rupp WD; Rockwell S Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053 [TBL] [Abstract][Full Text] [Related]
20. Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers. Streffer C; Tamulevicius P Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):571-5. PubMed ID: 8005816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]